Metraipolis › archive › dc_2f84bbcd7b5b
Effectiveness and Safety of Fixed-Dose Empagliflozin/Linagliptin Combination in Type 2 Diabetes Mellitus: Real-World Evidence From Bangladesh — Europe PMC PMID:41641179
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41641179
- DOI
- 10.7759/cureus.102858
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T07:43:39.190Z
- SHA-256 of the archived text
121e2f0dff0ea4e8979cdaba80bc1a48380f4d9a7d9f2b0b3e6f7fe0fcc4c43b- Stable URL of this page
https://metraipolis.com/documento/dc_2f84bbcd7b5b
How to cite
Effectiveness and Safety of Fixed-Dose Empagliflozin/Linagliptin Combination in Type 2 Diabetes Mellitus: Real-World Evidence From Bangladesh — Europe PMC PMID:41641179 — Europe PMC (en), https://europepmc.org/article/MED/41641179 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2f84bbcd7b5b (Metraipolis archive dc_2f84bbcd7b5b, sha256 121e2f0dff0ea4e8979cdaba80bc1a48380f4d9a7d9f2b0b3e6f7fe0fcc4c43b)
BibTeX
@misc{dc2f84bbcd7b5b,
title = {Effectiveness and Safety of Fixed-Dose Empagliflozin/Linagliptin Combination in Type 2 Diabetes Mellitus: Real-World Evidence From Bangladesh — Europe PMC PMID:41641179},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41641179},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2f84bbcd7b5b; sha256 121e2f0dff0ea4e8979cdaba80bc1a48380f4d9a7d9f2b0b3e6f7fe0fcc4c43b},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41641179. Agents can read the archived copy with the MCP tool read_document.